These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 9016896)

  • 41. [Seroconversion in response to a reinforced primary hepatitis B vaccination in children with cancer].
    Villena R; Zubieta M; Hurtado C; Salgado C; Silva G; Fernández J; Villarroel M; Fernández M; Brahm J; O'Ryan M; Santolaya ME
    Rev Chil Pediatr; 2015; 86(4):236-43. PubMed ID: 26298296
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Titers of antibodies to the surface antigen of hepatitis B virus after vaccination in relation to immunity-related gene variants. A prospective study among hemodialysis patients.
    Jodłowska-Siewert E; Jagodziński PP; Grzegorzewska AE
    Pol Arch Intern Med; 2017 Aug; 127(7-8):481-489. PubMed ID: 28817541
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibodies to HBV surface antigen in relation to interferon-λ3 in hemodialysis patients.
    Grzegorzewska AE; Świderska MK; Mostowska A; Warchoł W; Jagodziński PP
    Vaccine; 2016 Sep; 34(41):4866-4874. PubMed ID: 27595449
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Prevalence of response to anti-HBV infection in patients on maintenance hemodialysis infected with hepatitis C virus (HCV)].
    Muszytowski M; Manitius J; Ruszkiewicz-Fołda M
    Przegl Lek; 1996; 53(5):417-9. PubMed ID: 8754404
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Low dose revaccination induces robust protective anti-HBs antibody response in the majority of healthy non-responder neonates.
    Jafarzadeh A; Zarei S; Shokri F
    Vaccine; 2008 Jan; 26(2):269-76. PubMed ID: 18037544
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunogenicity and reactogenicity of a recombinant hepatitis B vaccine in subjects over age of forty years and response of a booster dose among nonresponders.
    Das K; Gupta RK; Kumar V; Kar P
    World J Gastroenterol; 2003 May; 9(5):1132-4. PubMed ID: 12717874
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term immunogenicity and efficacy of hepatitis B vaccine in hemodialysis patients.
    Buti M; Viladomiu L; Jardi R; Olmos A; Rodriguez JA; Bartolome J; Esteban R; Guardia J
    Am J Nephrol; 1992; 12(3):144-7. PubMed ID: 1415374
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Seroconversion and immune response after anti-HBV vaccination in patients on chronic hemodialysis: comparison of two vaccines].
    Polito P; Di Lullo L; Iannacci GR; Cecilia A; Galderisi C; Gorini A
    G Ital Nefrol; 2011; 28(5):525-30. PubMed ID: 22028266
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recombinant hepatitis B vaccine use in chronic hemodialysis patients. Long-term evaluation and cost-effectiveness analysis.
    Fabrizi F; Di Filippo S; Marcelli D; Guarnori I; Raffaele L; Crepaldi M; Erba G; Locatelli F
    Nephron; 1996; 72(4):536-43. PubMed ID: 8730417
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A Randomized Controlled Trial of Seroconversion After 20 Mg versus 40 mg Intramuscular Hepatitis B Virus Vaccination in Patients with Chronic Kidney Disease Stage 3.
    Krairittichai U; Sethakarun S
    J Med Assoc Thai; 2017 Feb; 100 Suppl 1():S1-7. PubMed ID: 29926711
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hepatitis C virus and the immunological response to hepatitis B virus vaccine in dialysis patients: meta-analysis of clinical studies.
    Fabrizi F; Dixit V; Martin P; Messa P
    J Viral Hepat; 2011 Dec; 18(12):871-6. PubMed ID: 22093033
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The immune response to hepatitis B vaccine in humans: inheritance patterns in families.
    Kruskall MS; Alper CA; Awdeh Z; Yunis EJ; Marcus-Bagley D
    J Exp Med; 1992 Feb; 175(2):495-502. PubMed ID: 1531063
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Longitudinal Hepatitis B Vaccine Cohort Demonstrates Long-lasting Hepatitis B Virus (HBV) Cellular Immunity Despite Loss of Antibody Against HBV Surface Antigen.
    Simons BC; Spradling PR; Bruden DJ; Zanis C; Case S; Choromanski TL; Apodaca M; Brogdon HD; Dwyer G; Snowball M; Negus S; Bruce MG; Morishima C; Knall C; McMahon BJ
    J Infect Dis; 2016 Jul; 214(2):273-80. PubMed ID: 27056956
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lack of response to recombinant hepatitis B vaccine in nonresponders to the plasma vaccine.
    Weissman JY; Tsuchiyose MM; Tong MJ; Co R; Chin K; Ettenger RB
    JAMA; 1988 Sep 23-30; 260(12):1734-8. PubMed ID: 2970557
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparison of responsiveness to hepatitis B vaccination in patients on hemodialysis and peritoneal dialysis.
    Liu YL; Kao MT; Huang CC
    Vaccine; 2005 Jun; 23(30):3957-60. PubMed ID: 15917117
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Anti-HBs persistence following primary vaccination with three doses of hepatitis B vaccine among normal and high-responder adults: a 3-year follow-up study].
    Lyu JJ; Zhang L; Yan BY; Liu JY; Feng Y; Song LZ; Chen SY; Zhou LB; Liang XF; Cui FQ; Wang FZ; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Jun; 50(6):478-83. PubMed ID: 27256725
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hepatitis B vaccination of premature infants: a reassessment of current recommendations for delayed immunization.
    Losonsky GA; Wasserman SS; Stephens I; Mahoney F; Armstrong P; Gumpper K; Dulkerian S; West DJ; Gewolb IH
    Pediatrics; 1999 Feb; 103(2):E14. PubMed ID: 9925860
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Suboptimal response to hepatitis B vaccine in drug users.
    Rumi M; Colombo M; Romeo R; Boschini A; Zanetti A; Gringeri A; Mannucci PM
    Arch Intern Med; 1991 Mar; 151(3):574-8. PubMed ID: 1848057
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Study on antibody response to revaccination of hepatitis B vaccine among firstly low-response adults].
    Feng Y; Yan BY; Zhang L; Lü JJ; Liu JY; Gong XH; Cui FQ; Liang XF; Chen SY; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2012 Sep; 46(9):813-7. PubMed ID: 23157885
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antibody response to hepatitis B vaccine in end-stage renal disease patients.
    Chow KM; Law MC; Leung CB; Szeto CC; Li PK
    Nephron Clin Pract; 2006; 103(3):c89-93. PubMed ID: 16534237
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.